AI to Novel Coronavirus COVID 19 and Epidemic Market Report 2025 (Global Edition)

Global AI to Novel Coronavirus COVID 19 and Epidemic Market Report 2024 Market Size Split by Type (AI Tracking, AI Prediction, AI Recognition, Other), by Application (Medical, Public Emergency, Othe...

AI to Novel Coronavirus COVID 19 and Epidemic Market Report Description

We have various report editions of AI to Novel Coronavirus COVID 19 and Epidemic Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

AI to Novel Coronavirus COVID 19 and Epidemic Market Insights Video

Competitive Landscape of the AI to Novel Coronavirus COVID 19 and Epidemic Market

The AI to Novel Coronavirus COVID-19 and Epidemic Market is characterized by the presence of numerous technology firms, healthcare providers, and research institutions that are leveraging AI to tackle the challenges posed by pandemics. Key players in this market include major tech giants such as Google, Microsoft, IBM, and Amazon, which have been at the forefront of developing AI-driven solutions for disease detection, tracking, and management.

November 2020: The European Commission announced that they have awarded Euro 55.2 million to projects which use digital health and artificial intelligence (AI) to contribute to the fight against COVID-19. Thirteen projects have been chosen to provide solutions to protect healthcare personnel, as well as to swiftly detect and halt the spread of COVID-19. (Source: https://digital-strategy.ec.europa.eu/en/news/coronavirus-eu552-million-granted-research-projects-dedicated-digital-health-technologies) September 2020: Enlitic, Inc. announced that they are collaborating with the Copenhagen-based hospitals (Herlev/Gentofte, Bispebjerg/Frederiksberg hospitals) to evaluate an AI-based algorithm in the reading chest x-rays. The medical software has been trained on chest radiographs and for the first time, it will be tested in a Nordic country. Following the validation process, the algorithm will be applied for a short time in the Nordic environment to demonstrate how medical AI will impact the workflow of Nordic healthcare providers in terms of speed, efficacy, and medical decision-making. (Source: https://enlitic.com/press/ai-based-algorithm-in-chest-radiographs-will-enable-quicker-and-more-consistent-diagnosis/)

Top Companies Market Share in AI to Novel Coronavirus COVID 19 and Epidemic Industry: (In no particular order of Rank)

• Google
• Alibaba
• Artificial Intelligence in Medical Epidemiology
• BlueDot
• Beijing Infervision Technology Co.
• Ltd.
• BenevolentAI
• SenseTime
• Insilico Medicine
• DEARGEN
• Iktos
• SRI Biosciences
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the AI to Novel Coronavirus COVID 19 and Epidemic Market

Which Region Dominates the AI to Novel Coronavirus COVID 19 and Epidemic Market in 2024?

According to Cognitive Market Research, North America dominates the AI to Novel Coronavirus COVID-19 and Epidemic Market due to its advanced healthcare infrastructure, significant investment in AI technology, and strong presence of key industry players. The region's robust research and development capabilities, combined with substantial funding from both government and private sectors, have accelerated the adoption of AI solutions in managing the pandemic. Additionally, North America's proactive approach in implementing innovative technologies for disease detection, monitoring, and response has further strengthened its leading position in this market.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific is the fastest-growing region in the AI to Novel Coronavirus COVID-19 and Epidemic Market due to its rapidly advancing technological infrastructure, increasing government initiatives, and significant investments in healthcare innovation. Countries like China, India, and South Korea are leading the charge with substantial funding and support for AI-driven solutions to combat the pandemic. The region's large population and the urgent need for efficient pandemic management have spurred the adoption of AI technologies for disease surveillance, diagnosis, and treatment. Additionally, strong collaboration between public and private sectors is driving the rapid growth and implementation of AI in healthcare across Asia Pacific.

 

The current report Scope analyzes AI to Novel Coronavirus COVID 19 and Epidemic Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America AI to Novel Coronavirus COVID 19 and Epidemic

According to Cognitive Market Research, the global AI to Novel Coronavirus COVID 19 and Epidemic market size was estimated at USD XX Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 3.2%from 2024 to 2031

• According to Cognitive Market Research, the US had a major share in the AI to Novel Coronavirus COVID 19 and Epidemic market with a market size of USD XX million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. The demand is amplified by the nation's urgent need for advanced technological solutions to combat the pandemic.
• The Canada AI to Novel Coronavirus COVID 19 and Epidemic market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 4.0% during the forecast period. Canada's urgent need for advanced technological solutions to combat the pandemic to increased usage of AI to Novel Coronavirus COVID 19 and Epidemic.
• The Mexico AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.7% during the forecast period,with a market size of USD XXmillion in 2024.

Europe AI to Novel Coronavirus COVID 19 and Epidemic

According to Cognitive Market Research, the global AI to Novel Coronavirus COVID 19 and Epidemic market size was estimated at USD XX Million out of which Europe held the market of more than 30% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 3.5%from 2024 to 2031

The France AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 2.7% during the forecast period,with a market size of USD XX million in 2024.

According to Cognitive Market Research, the Germany AI to Novel Coronavirus COVID 19 and Epidemic market size was valued at USD XXmillion in 2024 and is projected to grow at a CAGR of 3.7% during the forecast period. In Germany, AI to Novel Coronavirus COVID 19 and Epidemic sales surged due to the continent's proactive approach to leveraging advanced technologies in pandemic response.

The Italy AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD XX million in 2024.

The Russia AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.5% during the forecast period,with a market size of USD XX million in 2024.

The Spain AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 2.6% during the forecast period with a market size of USD XX million in 2024

The LuxembourgAI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.6%during the forecast period, with a market size of USD XXmillion in 2024.

The PortugalAI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.3%during the forecast period, with a market size of USD XXmillion in 2024.

The GreeceAI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.8%during the forecast period, with a market size of USD XX million in 2024.

Rest of Europe'sAI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD XXmillion in 2024.

Asia Pacific AI to Novel Coronavirus COVID 19 and Epidemic

According to Cognitive Market Research, the global AI to Novel Coronavirus COVID 19 and Epidemic market size was estimated at USD XXMillion, out of which Asia Pacific held the market ofaround23% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0%from 2024 to 2031

• According to Cognitive Market Research, the China AI to Novel Coronavirus COVID 19 and Epidemic market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. AI to Novel Coronavirus COVID 19 and Epidemic sales surge in China due to the rapid technological adoption and extensive government initiatives.
• The Japan AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD XX million in 2024.
• The India AI to Novel Coronavirus COVID 19 and Epidemic market had a market share of USD XX million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. India's rapid technological adoption and extensive government initiatives.
• The South Korea AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 6.1% during the forecast period, with a market size of USD XX million in 2024.
• The Australia AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 6.7% during the forecast period,with a market size of USD XX million in 2024.
• The South East Asia AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 8.0%during the forecast period, with a market size of USD XXmillion in 2024.
• The Rest of Asia Pacific AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD XXmillion in 2024.

South America AI to Novel Coronavirus COVID 19 and Epidemic

According to Cognitive Market Research, the global AI to Novel Coronavirus COVID 19 and Epidemic market size was estimated at USD XX Million out of which Latin America market of more than 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.4%from 2024 to 2031

• According to Cognitive Market Research, the Brazil AI to Novel Coronavirus COVID 19 and Epidemic market size was valued at USD XX million in 2024 and is projected to grow at a CAGR of 5.0% during the forecast period. AI to Novel Coronavirus COVID 19 and Epidemic sales flourish in Brazil due to the digital healthcare adoption and increased awareness of the importance of AI-driven solutions.
• Argentina AI to Novel Coronavirus COVID 19 and Epidemic market had a market share of USD XXmillion in 2024 and is projected to grow at a CAGR of 5.3% during the forecast period. Argentina's digital healthcare adoption and increased awareness of the importance of AI-driven solutions.
• Colombia AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 4.2% during the forecast period with a market size of USD XX million in 2024.
• Peru AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 4.6% during the forecast period with a market size of USD XX million in 2024.
• Chile AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 4.7% during the forecast period with a market size of USD XX million in 2024.
• The Rest of Latin America AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.5% during the forecast period, with a market size of USD XX million in 2024.

Middle East and Africa AI to Novel Coronavirus COVID 19 and Epidemic

According to Cognitive Market Research, the global AI to Novel Coronavirus COVID 19 and Epidemic market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD XXmillion in 2024 and will grow at a compound annual growth rate (CAGR) of 4.7%from 2024 to 2031

• The GCC Countries AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 5.5% during the forecast period with a market size of USD XX million in 2024. AI to Novel Coronavirus COVID 19 and Epidemic sales flourish due to the healthcare innovation and the urgent need to address public health emergencies effectively.
• The Egypt AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD XX million in 2024.
• The South Africa AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 5.7% during the forecast period,with a market size of USD XX million in 2024. AI to Novel Coronavirus COVID 19 and Epidemic sales flourish in South Africa due to the healthcare innovation and the urgent need to address public health emergencies effectively.
• The Turkey AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 4.2% during the forecast period,with a market size of USD XX million in 2024.
• The Nigeria AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.8% during the forecast period,with a market size of USD XX million in 2024.
• The Rest of MEA AI to Novel Coronavirus COVID 19 and Epidemic market is projected to witness growth at a CAGR of 3.7% during the forecast period,with a market size of USD XX million in 2024.

AI to Novel Coronavirus COVID 19 and Epidemic Market Analysis

AI to Novel Coronavirus COVID 19 and Epidemic Market Type Segment Analysis

According to Cognitive Market Research, the AI Tracking category emerges as the dominant segment. This dominance can be attributed to the increasing need for real-time monitoring of virus spread, which helps in implementing timely interventions and control measures. AI Tracking systems leverage advanced algorithms and vast datasets to provide accurate and up-to-date information on infection rates, hotspots, and movement patterns of affected individuals.

The AI Recognition category is projected to be the fastest-growing segment in this market. This rapid growth is driven by the heightened focus on improving diagnostic accuracy and speed. AI Recognition technologies, which include image and facial recognition, have been crucial in identifying symptomatic individuals through thermal imaging and other biometric data. The need for swift, non-invasive screening methods in high-traffic areas like airports and public transport hubs has propelled the adoption of AI Recognition solutions.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of AI to Novel Coronavirus COVID 19 and Epidemic Industry. Request a Free Sample PDF!

AI to Novel Coronavirus COVID 19 and Epidemic Market Application Segment Analysis

According to Cognitive Market Research, the Medical application category is the dominant segment. This dominance is driven by the critical role AI plays in enhancing diagnostic accuracy, optimizing treatment plans, and accelerating drug discovery. During the COVID-19 pandemic, AI applications in the medical field enabled rapid analysis of medical imaging, such as CT scans and X-rays, to detect viral pneumonia accurately. Furthermore, AI algorithms facilitated the development of new vaccines and therapeutic solutions by analyzing vast amounts of biomedical data at unprecedented speeds, making the medical application indispensable in managing and combating the virus.

The Public Emergency application category is the fastest-growing segment in this market. This rapid growth is attributed to the increasing need for AI-driven solutions in managing public health crises and emergency response. AI technologies have proven invaluable in predicting outbreaks, optimizing resource allocation, and enhancing communication strategies during pandemics. During COVID-19, AI was used to model virus spread, enabling authorities to implement effective containment measures and allocate medical resources efficiently.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion